Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population

Nephrology Dialysis Transplantation

Volumn 27, Issue 1, 2012, Pages 429-434

  Liem, Ylian S ^a   Wong, John B ^b   Winkelmayer, Wolfgang C ^c   Weimar, Willem ^a   Wetzels, Jack F M ^d   De Charro, Frank Th ^e   Kaandorp, Guido C ^a   Stijnen, Theo ^f   Hunink, M G Myriam ^a,g  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Dutch End Stage Renal Disease Registry RENINE   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

decision analysis; dialysis; living donor renal transplantation; preemptive renal transplantation; survival

Indexed keywords

ADULT; AGED; ARTICLE; CADAVER KIDNEY; COMPUTER SIMULATION; CONTROLLED STUDY; DECISION TREE; EARLY INTERVENTION; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; NETHERLANDS; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; TREATMENT PLANNING;

ADULT; AGED; CADAVER; COMPUTER SIMULATION; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MODELS, THEORETICAL; NETHERLANDS; PROGNOSIS; QUALITY-ADJUSTED LIFE YEARS; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

EID: 84856667233     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr294     Document Type: Article

References (25)

1. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 2002; 74: 1377-1381 (Pubitemid 35379540)
2. Papalois VE, Moss A, Gillingham KJ et al. Pre-emptive transplants for patients with renal failure: an argument against waiting until dialysis. Transplantation 2000; 70: 625-631 (Pubitemid 30659647)
3. U.S. Renal Data System. USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007
4. Kasiske BL, Snyder JJ, Matas AJ et al. Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol 2002; 13: 1358-1364 (Pubitemid 34441417)
5. Simforoosh N, Basiri A, Pourrezagholi F et al. Is preemptive renal transplantation preferred? Transplant Proc 2003; 35: 2598-2601 (Pubitemid 37378080)
6. Joo KW, Shin SJ, Lee SH et al. Preemptive transplantation and long-term outcome in living donor kidney transplantation, single-center experience. Transplant Proc 2007; 39: 3061-3064 (Pubitemid 350251471)
7. Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 2001; 344: 726-731 (Pubitemid 32204990)
8. Gill JS, Tonelli M, Johnson N et al. Why do preemptive kidney transplant recipients have an allograft survival advantage? Transplantation 2004; 78: 873-879 (Pubitemid 39298531)
9. Ibrahim HN, Foley R, Tan L et al. Long-term consequences of kidney donation. N Engl J Med 2009; 360: 459-469
10. Kido R, Shibagaki Y, Iwadoh K et al. Very low but stable glomerular filtration rate after living kidney donation: is the concept of "chronic kidney disease" applicable to kidney donors? Clin Exp Nephrol 2010; 14: 356-362
11. Lentine KL, Schnitzler MA, Xiao H et al. Racial variation in medical outcomes among living kidney donors. N Engl J Med 2010; 363: 724-732
12. Zimmerman D, Albert S, Llewellyn-Thomas H et al. The influence of socio-demographic factors, treatment perceptions and attitudes to living donation on willingness to consider living kidney donor among kidney transplant candidates. Nephrol Dial Transplant 2006; 21: 2569-2576 (Pubitemid 44644533)
13. Liem YS, Bosch JL, Hunink MG. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health 2008; 11: 733-741 (Pubitemid 352032818)
14. Gold MR, Siegel JE, Russell LB et al. Cost-Effectiveness in Health and Medicine, 1st edn. New York, NY: Oxford University Press; 1996
15. Hemke AC, Heemskerk MB, Haase BJ et al. Which factors influence the number of hospitalization days in the first three months after kidney transplantation? In. 13th Congress of the European Society for Organ Transplantation. Prague, Czech Republic, 2007, p. 84
16. Centraal Bureauvoorde Statistiek. www.cbs.nl. (vol 2007), Voorburg/Heerlen, the Netherlands, (23 November 2007, date last accessed)
17. ERA-EDTA Registry. ERA-EDTA Registry 2005 Annual Report. Amsterdam, The Netherlands: Academic Medical Center, Department of Medical Informatics, 2007
18. Inrig JK, Sun JL, Yang Q et al. Mortality by dialysis modality among patients who have end-stage renal disease and are awaiting renal transplantation. Clin J Am Soc Nephrol 2006; 1: 774-779
19. Medin C, Elinder CG, Hylander B et al. Survival of patients who have been on a waiting list for renal transplantation. Nephrol Dial Transplant 2000; 15: 701-704 (Pubitemid 30242991)
20. Kramar R, Oberbauer R. Annual Report 2006. http://www.nephro.at/oedr2006/ oedr2006.htm (8 January 2008, date last accessed). Austrian Dialysis and Transplantation Registry (OEDTR), Austrian Society of Nephrology, 2006
21. Weng FL, Mange KC. A comparison of persons who present for preemptive and nonpreemptive kidney transplantation. Am J Kidney Dis 2003; 42: 1050-1057 (Pubitemid 37322922)
22. Winkelmayer WC, Owen WF Jr, Levin R et al. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 2003; 14: 486-492 (Pubitemid 36150874)
23. Winkelmayer WC, Mehta J, Chandraker A et al. Predialysis nephrol-ogist care and access to kidney transplantation in the United States. Am J Transplant 2007; 7: 872-879 (Pubitemid 46481181)
24. Goldfarb-Rumyantzev A, Hurdle JF, Scandling J et al. Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant 2005; 20: 167-175 (Pubitemid 40207623)
25. Matas AJ, Payne WD, Sutherland DE et al. 2,500 living donor kidney transplants: a single-center experience. Ann Surg 2001; 234: 149-164 (Pubitemid 32729421)